Mass General Brigham, AvoMD partner for rapid response care workflows

Health system Mass General Brigham is teaming up with clinical decision support company AvoMD to help rapid response teams identify patients at risk of fatal respiratory or cardiac arrest outside of the ICU.

AvoMD transforms PDF guidelines and static decision-tree protocols into actionable digital tools that can be made available in the clinical workflow via electronic health record (EHR) integration and mobile apps.

Suppose a nurse on the rapid response team sees a patient with an abnormal heart rate (tachycardia). In that case, AvoMD processes the patient’s vital signs and then notifies the nurse of the best next step based on hospital-specific protocols.

Alternatively, if a nurse wants to quickly reference some of the latest evidence on tachycardia in patients with specific comorbidity, they can pull up the AvoMD mobile app and obtain patient-specific guidance within seconds.

AvoMD’s enterprise solution functions with strict governance, while health system “builders” or super admins have access to the platform and can customize it.

End users see the Avo Point of Care App or Avo tab in their EHR as a clinician-facing tool available in their workflow.

Other health systems can adopt the tools MGB creates on AvoMD and use as-is or customize as needed.

AvoMD cofounder and Head of Product and Engineering Joongheum Park told MobiHealthNews via email that the company also layers actions on top of pathways.

“This allows health systems to reduce clinician burnout by offering clinicians an end-to-end, HIPAA secure, workflow solution in the EHR that automates tasks through the entire clinical journey from pre-encounter to in-visit to post-visit workflows,” he said.

Park said the impact of the work will be assessed by the Healthcare Transformation Lab, a research team at Massachusetts General Hospital, along with quantitative and qualitative measures, using a mix of analytics and user surveys to collect data.

“Insights from this data will be used to further refine the underlying clinical pathways, improve the user experience, and assess timing and scope for wider AvoMD deployment,” Park said.  

THE LARGER TREND

Last year, AI-enabled AvoMD closed a $5 million seed funding round led by AlleyCorp. 

As data analytics capabilities in healthcare evolve, the technology is offering care teams and physicians faster access to patient information and has the potential to streamline workflows and improve care.

Reveleer’s AI platform, for example, focuses on risk adjustment, quality improvement and providing medical record services by integrating patient data and offering workflow solutions for revenue optimization and risk management across various healthcare programs.